ArticleOne health outlook2025
Antibiotic resistance profiles of oral flora in hippopotami (Hippopotamus amphibius): implications for treatment of human bite wound infections.
Article in One health outlook, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe common hippopotamus (Hippopotamus amphibius) is found in aquatic environments throughout sub-Saharan Africa and is known to cause attacks on humans living or working close to water bodies. Victims surviving an attack often suffer from the consequences of severe wound infections caused by the animal's sharp canine teeth.
objectiveIsolation of normal flora bacteria from the oral cavity of common hippopotami (Hippopotamus amphibious) followed by antibiotic susceptibility testing to aid in the identification of a targeted antibiotic treatment regimen for hippopotamus attack victims.
methodsOral swabs were collected from 34 free-ranging hippopotami in three reserves within the Greater Kruger National Park Complex in South Africa and cultured for aerobic and anaerobic bacteria. Antibiotic susceptibility testing was conducted using the disc diffusion method (Kirby-Bauer method) and a panel of 16 antibiotic drugs representing 10 antibiotic categories.
resultsCulturing of 50 oral swab samples from 34 hippopotami yielded 188 aerobic isolates belonging to 30 bacterial genera and 41 bacterial species (Gram-negative: 70.7%; Gram-positive: 29.3%) and 16 obligate anaerobic isolates from two genera. Three bacterial species, namely Aeromonas hydrophila, Aeromonas sobria and Shewanella putrefaciens accounted for 52% of the aerobic isolates. The anaerobic isolates were identified as Prevotella melaninogenica and Clostridium spp. Antimicrobial susceptibility testing was performed for 112 aerobic isolates (Gram-negative: 93 (83%); Gram-positive: 19 (17%)) representing all isolated bacterial species. High levels of antibiotic resistance were observed among the Gram-negative species especially to most beta-lactam antibiotics (50.5% to 80.7%). Multidrug resistance was detected in 22.6% of Gram-negative isolates and in 24.1% of all isolates.
conclusionsThis study provides the first investigation of the oral flora bacteria of the common hippopotamus. Among the 32 mostly aerobic bacterial genera the most abundant bacterial species were A. hydrophila, A. sobria and S. putrefaciens. They are typical inhabitants of the aquatic habitat of the hippopotamus and of zoonotic importance as opportunistic human pathogens. The antibiotic susceptibility profiles demonstrated that quinolones, aminoglycosides, and tetracyclines were highly efficacious against these bacterial species which otherwise showed moderate to high levels of resistance to the traditional bite wound treatment with amoxicillin/clavulanate and 1st and 2nd generation cephalosporins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.